Ryan A Gregg
Overview
Explore the profile of Ryan A Gregg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
192
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cavallari L, Van Driest S, Prows C, Bishop J, Limdi N, Pratt V, et al.
Genet Med
. 2019 Mar;
21(10):2255-2263.
PMID: 30894703
Purpose: A number of institutions have clinically implemented CYP2D6 genotyping to guide drug prescribing. We compared implementation strategies of early adopters of CYP2D6 testing, barriers faced by both early adopters...
2.
Hicks C, Gregg R, Nayak S, Cannella L, Schena G, Tallarida C, et al.
Psychopharmacology (Berl)
. 2017 Mar;
234(11):1671-1681.
PMID: 28251297
Rationale: Metabotropic glutamate 2 and 3 (mGluR2/3) receptors are implicated in drug addiction as they limit excessive glutamate release during relapse. N-acetylaspartylglutamate (NAAG) is an endogenous mGluR2/3 agonist that is...
3.
Simmons S, Gregg R, Tran F, Mo L, von Weltin E, Barker D, et al.
Addict Biol
. 2016 Dec;
23(1):102-110.
PMID: 27910188
Abuse of synthetic psychostimulants like synthetic cathinones has risen in recent years. 3,4-Methylenedioxypyrovalerone (MDPV) is one such synthetic cathinone that demonstrates a mechanism of action similar to cocaine. Compared to...
4.
Gregg R, Hicks C, Nayak S, Tallarida C, Nucero P, Smith G, et al.
Neuropharmacology
. 2016 Apr;
108:111-9.
PMID: 27085607
Synthetic cathinones produce dysregulation of monoamine systems, but their effects on the glutamate system and the influence of glutamate on behavioral effects related to cathinone abuse are unknown. A principal...
5.
Vouga A, Gregg R, Haidery M, Ramnath A, Al-Hassani H, Tallarida C, et al.
Neuropharmacology
. 2014 Dec;
91:109-16.
PMID: 25496724
Knowledge about the neuropharmacology of mephedrone (MEPH) applies primarily to the racemate, or street form of the drug, but not to its individual enantiomers. Here, through chemical isolation of MEPH...
6.
Gregg R, Baumann M, Partilla J, Bonano J, Vouga A, Tallarida C, et al.
Br J Pharmacol
. 2014 Sep;
172(3):883-94.
PMID: 25255824
Background And Purpose: Synthetic cathinones, commonly referred to as 'bath salts', are a group of amphetamine-like drugs gaining popularity worldwide. 4-Methylmethcathinone (mephedrone, MEPH) is the most commonly abused synthetic cathinone...
7.
Gregg R, Rawls S
Life Sci
. 2013 Nov;
97(1):27-30.
PMID: 24231450
"Bath salts" is one street name for a family of synthetic cathinones that display pharmacological effects resembling cocaine and commonly abused amphetamines. Despite extensive legislation aimed at the criminalization of...
8.
Gregg R, Tallarida C, Reitz A, Rawls S
Behav Pharmacol
. 2013 Oct;
24(8):684-8.
PMID: 24126218
Concurrent use of mephedrone (4-methylmethcathinone; MEPH) and established drugs of abuse is now commonplace, but knowledge about interactions between these drugs is sparse. The present study was designed to test...
9.
Gregg R, Tallarida C, Reitz A, McCurdy C, Rawls S
Drug Alcohol Depend
. 2013 Jul;
133(2):746-50.
PMID: 23890492
Background: The present study tested the hypothesis that mephedrone (MEPH) produces behavioral sensitization (i.e., a progressive increase in motor response during repeated psychostimulant exposure) in rats. Methods: MEPH was administered...